Publikationsliste

(Die Liste können Sie hier auch als PDF herunterladen.)

Original Publications in peer-reviewed Journals

1. Paus, R., Maurer, M., Slominski, A., and Czarnetzki, B. M.: Mast cell involvement in murine hair growth. Dev. Biol. 1994: 163; 230-240. IF: 4.7
2. Slominski, A., Paus, R., Plonka, P., Chakraborty, A., Maurer, M., Pruski, D., and Lukiewicz, S.: Melanogenesis during the anagen-, catagen-, telogen transformation of the murine hair follicle. J. Invest. Dermatol. 1994: 102; 862-869. IF: 3.6
3. Slominski, A., Chassalevris, N., Mazurkiewicz, J., Maurer, M., and Paus, R.: Murine skin as a target for melatonin bioregulation. Exp. Dermatol. 1994: 3; 45-50. IF: DNA
4. Paus, R., Heinzelmann, T., Robiscek, S., Czarnetzki, B. M., and Maurer, M.: Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch. Dermatol. Res. 1994: 287; 500-502. IF: 1.33
5. Maurer, M., Paus, R., and Czarnetzki, B. M.: Mast cells as modulators of hair follicle cycling. Exp. Dermatol. 1995: 4; 266-271. IF: DNA
6. Paus, R., Böttge, J. A., Czarnetzki, B. M., and Maurer, M.: Hair growth control by immunosuppression. Arch. Dermatol. Res. 1996: 288; 408-410. IF: 1.47
7. Slominski, A., Paus, R., Plonka, P., Handjiski, B., Maurer, M., Chakraborty, A., and Mihm, M.: Pharmacological disruption of hair follicle pigmentation by cyclophosphamid as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J. Invest. Dermatol. 1996: 106; 1203-1211. IF: 4.7
8. Maurer, M., Handjiski, B., and Paus, R.: Hair growth modulation by topical immunophilin ligands: Induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am. J. Pathol. 1997: 150; 1433-1441. IF: 6.5
9. Slominski, A., Goodman-Snitkoff, G., Maurer, M., and Paus, R.: Hair cycle-associated changes in splenocyte proliferation. In Vivo 1997: 11; 101-102. IF: 0.44
10. Maurer, M., Opitz, M., Henz, B. M., and Paus, R.: The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J. Dermatol. Sci. 1997: 16; 79-84. IF: 0.57
11. Botchkarev, V. A., Eichmüller, S., Peters, E., Pietsch, P., Johansson, O., Maurer, M., and Paus, R.: A simple immunofluorescent technique for simultaneous visualisation of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell-nerve fibre contacts in murine skin. Arch. Dermatol. Res. 1997: 289; 292-302. IF: 1.23
12. Maurer, M., Fischer, E., Handjiski, B., Stebut, E. von, Algermissen, B., Bavandi, A., and Paus, R.: Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab. Invest. 1997: 77; 319-332. IF: 4.65
13. Prodeus, A., Zhou, X., Maurer, M., Galli, S. J., and Carroll, M. C.: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997: 390; 172-175. IF: 27.36
14. Stebut, E. von, Maurer, M., and Zuberbier, T.: Intoleranzreaktion auf systemische Kortikosteroide. Allergologie 1997: 7; 336-339. IF: 0.56
15. Biró, T., Maurer, M., Modarres, S., Lewin, N. E., Brodie, C., Acs, G., Acs, P., Paus, R., and Blumberg, P.: Characterization of functional vanilloid receptors – expressed by mast cells. Blood 1998: 91; 1332-1340. IF: 8.3
16. Maurer, M., Peters, E. M. J., Botchkarev, V. A., and Paus, R.: Intact hair follicle innervation is not essential for anagen induction and development. Arch. Dermatol. Res. 1998: 290; 574-578. IF: 1.42
17. Boesiger, J., Tsai, M., Maurer, M., Yamaguchi, M., Brown, L. F., Claffey, K. P., Dvorak, H. F., and Galli, S. J.: Mast cells can secret VPF/VEGF and exhibit enhanced release after IgE-dependent upregulation of FceRI expression. J. Exp. Med. 1998: 188; 1135-1145. IF: 15.88
18. Maurer, M., Echtenacher, B.*, Hültner, L.*, Kollias, G., Männel, D. N., Langley, K. E., and Galli, S. J.: The c-kit ligand, stem cell factor, can enhance immunity through effects on mast cells. J. Exp. Med. 1998: 188; 1-6. IF: 15.88
19. Rosenkranz, A. R., Coxon, A.*, Maurer, M.*, Gurish, M. F., Austen, K. F., Friend, D. S., Galli, S. J., and Mayadas, T. N.: Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J. Immunol. 1998: 161; 6463-6467. IF: 7.16
20. Botchkarev, V. A., Peters, E. M., Botchkareva, N. V., Maurer, M., and Paus, R.: Hair cycle-dependent changes in adrenergic skin innervation and hair growth modulation by adrenergic drugs. J. Invest. Dermatol. 1999: 113; 878-887. IF: 4.9
21. Peters, E. M., Maurer, M., Botchkarev, V. A., Gordon, D. S., and Paus, R.: Hair growth-modulation by adrenergic drugs. Exp. Dermatol. 1999: 8; 274-281. IF: 2.1
22. Paus, R., Müller-Röver, S., Van Der Veen, C., Maurer. M., Eichmüller, S., Ling, G., Hofmann, U., Foitzik, K., Mecklenburg, L., and Handjiski, B.: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J. Invest. Dermatol. 1999: 113; 523-532. IF: 4.9
23. Maurer, M., Tsai, M., Metz, M., Fish, S., Korsmeyer, S. J., and Galli, S. J.: A role for Bax in the regulation of apoptosis in mouse mast cells. J. Invest. Dermatol. 2000: 114; 1205-1206. IF: 4.54
24. Foitzik, K., Lindner, G., Mueller-Roever, S., Maurer, M., Botchkareva, N., Botchkarev, V., Handjiski, B., Metz, M., Hibino, T., Soma, T., Dotto, G. P., and Paus, R.: Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J. 2000: 14; 752-760. IF: 9.25
25. Cindik, E. D., Maurer, M., Hannan, M. K., Müller, R., Hayes, W. C., Hovy, L., and Kurth, A.: Phenotypical characterization of c-kit receptor deficient mouse femurs using non-destructive high-resolution imaging techniques and biomechanical testing. Technol. Health Care 2000: 8; 267-275. IF: DNA
26. Gommerman, J. L.*, Oh, D. Y.*, Zhou, X., Tedder, T. F., Maurer, M., Galli, S. J., and Carroll, M. C.: A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol. 2000: 165; 6915-6921. IF: 6.83
27. Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M., Gilchrest, B. A., and Gudkov, A. V.: p53 is essential for chemotherapy-induced hair loss. Cancer Res. 2000: 60; 5002-5006. IF: 8.46
28. Botchkarev, V. A., Komarova, E. A, Siebenhaar, F., Botchkareva, N. V., Sharov, A. A., Komarov, P. G., Maurer. M., Gudkov, A. V., and Gilchrest, B. A.: p53 involvement in the control of murine hair follicle regression. Am. J. Pathol. 2001: 158; 1913-1919. IF: 7.1
29. Peters, E. M., Tobin, D. J., Botchkareva, N., Maurer, M., and Paus, R.: Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J. Histochem. Cytochem. 2002: 50; 751-766. IF: 1.15
30. Stebut, E. von, Metz, M., Milon, G., Knop, J., and Maurer, M.: Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-I alpha/beta released from neutrophils recruited by mast cell-derived TNF. Blood 2003: 101; 210-215. IF: 10.12
31. Weber, A., Knop, J., and Maurer, M.: Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br. J. Dermatol. 2003: 148; 224-228. IF: 2.69
32. Maurer, M., Seidel-Guyenot, W., Metz, M., Knop, J., and Steinbrink, K.: Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J. Clin. Invest. 2003: 112; 432-439. IF: 14.3
33. Peters, E. M., Maurer, M., Botchkarev, V. A., deMasey Jensen, K., Welker, P., Scott, G. A., and Paus, R.: Kit is expressed by epithelial cells in vivo. J. Invest. Dermatol. 2003: 121; 976-984. IF: 4.19
34. Metz, M., Botchkarev, V. A., Botchkareva, N. V., Welker, P., Tobin, D., Knop, J., Maurer, M., and Paus, R.: Neurotrophin-3 regulates mast cell functions in neonatal mouse skin. Exp. Dermatol. 2004: 13; 273-281. IF: 1.7
35. Giménez-Arnau, A. M., Ferrer-Puga, M., Peter, H.-J., Maurer, M., and Pujol-Vallverdú, R. M.: Chronic urticaria: Prospective ethiologic study and autoimmune syndrome significance. Acta Dermo-Sifiliográfica 2004: 95; 560-566. IF: DNA
36. Siebenhaar, F., Staubach, P., Metz, M., Magerl, M., Jung, J., and Maurer, M.: Peltier effect-based temperature challenge - an improved method for diagnosing cold urticaria. J. Allergy Clin. Immunol. 2004: 114; 1224-1225. IF: 7.2
37. Maurer, M.*, Wedemeyer, J.*, Metz, M., Chatterjea, D., Clouthier, D. E., Yanagisawa, M., Tsai, M., and Galli, S. J.: Mast cells promote homeostasis by limiting endothelin-1 induced toxicity. Nature 2004: 432; 512-516. IF: 32.18
38. Maurer, M., and Galli, S. J.: Lack of significant skin inflammation during elimination by apoptosis of large numbers of mouse cutaneous mast cells after cessation of treatment with SCF. Lab. Invest. 2004: 84; 1593-1602. IF: 3.7
39. Orinska, Z., Bulanova, E., Budagian, V., Metz, M., Maurer, M., and Bulfone-Paus, S.: TLR3-induced activation of mast cells modulates CD8+ T cell-recruitment. Blood 2005: 106; 978-987. IF: 10.13
40. Hochegger, K., Siebenhaar, F., Vielhauer, V., Heininger, D., Mayadas, T. N., Mayer, G., Maurer, M., and Rosenkranz, A. R.: Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 2005: 35; 3074-3082. IF: 4.87
41. Hochegger, K., Rosenkranz, A.R., Siebenhaar, F., and Maurer, M.: Comment on „Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis”. J. Immunol. 2006: 177; 1377.
42. Weber, A., and Maurer, M.: Skin site mast cell numbers correlate with rates of nodular growth, but not incidence, of basal cell carcinoma. Dermatology 2005: 211; 298-299. IF: 1.83
43. Hendrix, S.*, Warnke, K.*, Siebenhaar, F., Peters, E. M. J., Nitsch, R., and Maurer, M.: The majority of brain mast cells in B10.PL mice is present in the hippocampal formation. Neurosci. Lett. 2006: 392; 174-177. IF: 2.09
44. Staubach, P., Eckhardt-Henn, A., Dechene, M., Hanau, A., Metz, M., Magerl, M., Breuer, P., and Maurer, M.: Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br. J. Dermatol. 2006: 154; 294-298. IF: 3.33
45. Staubach, P., Onnen, K., Vonend, A., Metz, M., Siebenhaar, F., Tschentscher, I., Opper, B., Magerl, M., Lüdtke, R., Kromminga, A., and Maurer, M.: Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: A placebo-controlled trial. Dermatology 2006: 212; 150-159. IF: 1.85
46. Weller, K., Foitzik, F., Paus, R., Syska, W., and Maurer, M.: Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006: 20; 2366-2368. IF: 6.72
47. Maurer, M., Lopez Kostka, S., Siebenhaar, F., Moelle, K., Metz, M., Knop, J., and von Stebut, E.: Skin mast cells control T cell-dependent host defence in Leishmania major infections. FASEB J. 2006: 20; 2460-2467. IF: 6.72
48. Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M., Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B.: EAACI/GA²LEN guideline: Management of urticaria. Allergy 2006: 61; 321-331. IF: 5.33
49. Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M., Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B.: EAACI/GA²LEN guideline: Definition, classification, and diagnosis of urticaria. Allergy 2006: 61; 316-320. IF: 5.33
50. Metz, M., Lammel, V., Gibbs, B.F., and Maurer, M.: Inflammatory murine skin responses to UV-B light are partially dependent on Endothelin-1 and mast cells. Am. J. Pathol. 2006: 169; 815-822. IF: 5.92
51. Siebenhaar, F., Sharov, A. A., Peters, E. M. J., Sharova, T. Y., Syska, W., Mardaryev, A. N., Freyschmidt-Paul, P., Sundberg, J. P., Maurer, M., and Botchkarev, V. A.: Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata). J. Invest. Dermatol. 2007: 127; 1489-1497. IF: 4.83
52. Magerl, M., Philipp, S., Manasterski, M., Friedrich, M., and Maurer, M.: Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J. Allergy Clin. Immunol. 2007: 119; 752-754. IF: 8.12
53. Siebenhaar, F., Syska, W., Weller, K., Magerl, M., Zuberbier T., Metz, M., and Maurer, M.: Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am. J. Pathol. 2007: 170; 1910-1916. IF: 5.49
54. Siebenhaar, F., Kühn, W., Zuberbier, T., and Maurer, M.: Successful treatment of cutaneous mastocytosis and menière’s disease with anti-IgE therapy. J. Allergy Clin. Immunol. 2007: 120; 213-215. IF: 8.12
55. Staubach-Renz, P., von Stebut, E., Bräuninger, W., Maurer, M., and Steinbrink, K.: Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins. Hautarzt 2007: 58; 693-697. IF: 0.33
56. Maurer, M., and Zuberbier, T.: Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy 2007: 62; 1057-1063. IF: 5.01
57. Orinska, Z.*, Maurer, M.*, Mirghomizadeh, F.*, Bulanova, E., Metz, M., Nashkevich, N., Schiemann, F., Schulmistrat, J., Budagian, V., Giron-Michel, J., Brandt, E., Paus, R., and Bulfone-Paus, S.: IL-15 constrains mast cell-dependent anti-bacterial defenses by suppressing chymase activities. Nature Medicine 2007: 13; 927-934. IF: 26.38
58. Magerl, M., Schmolke, J, Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.: Acquired cold urticaria symptoms can be safely prevented by Ebastine. Allergy 2007: 62; 1465-1468. IF: 5.01
59. Metz, M., Bergmann, P., Zuberbier, T., and Maurer, M.: Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008: 63; 247-249. IF: 6.20
60. Magerl, M., Lammel, V., Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.: Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008: 17; 427-435. IF: 3.26
61. Młynek, A., Zalewska-Janowska, A., Martus, P., Staubach, P., Zuberbier, T., and Maurer, M.: How to assess disease activity in patients with chronic urticaria? Allergy 2008: 63; 777-780. IF: 6.20
62. Siebenhaar, F., Magerl, M., Peters, E. M. J., Hendrix, S., Metz, M., and Maurer, M.: Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J. Allergy Clin. Immunol. 2008: 121; 955-961. IF: 9.77
63. Caucig, P., Lescau, S., Knop, J., Maurer, M., and von Stebut, E.: Immediate type hypersensitivity against recombinant interleukin-2? J. Dtsch. Dermatol. Ges. 2008: 6; 956-956. IF: DNA
64. Vieira dos Santos, R., Młynek, A., Lima, H. C., Martus, P., and Maurer, M.: Beyond flat weals: validation of a three-dimensional imaging technology that will improve skin allergy research. Clin. Exp. Dermatol. 2008: 33; 772-775. IF: 1.78
65. Güzelbey, O., Ardelean, E., Magerl, M., Zuberbier, Maurer, M., and Metz, M.: Successful Treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008: 63; 1559-1565. IF: 6.20
66. Zuberbier, T., Maurer, M., and Augustin, M.: Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians. Allergy 2008: 63; 1560-1561. IF: 6.20
67. Staubach, P., Vonend, A., Burow, G., Metz, M., Magerl, M., and Maurer, M.: Patients with chronic urticaria exhibit increased rates of sensitization to Candida albicans, but not to common moulds. Mycoses 2008: 52; 334-338. IF: 1.53
68. Vieira dos Santos, R., Metz, M., Lima, H. C., Martus, P., and Maurer, M.: Differential effects of skin nerves on allergic skin inflammation. Allergy 2009: 64; 496-498. IF: TBD (IF 2008: 6.20)
69. Maurer, M., Ortonne, J.-P., and Zuberbier, T.: Chronic urticaria: an internet survey of patient survey on health behaviours, symptom patterns, and treatment needs in European adult patients. Br. J. Dermatol. 2009: 160; 633-641. IF: TBD (IF 2008: 3.49)
70. Maurer, M., Ortonne, J.-P., and Zuberbier, T.: Chronic urticaria: A patient survey on quality-of-life, treatment usage, and doctor-patient relation. Allergy 2009: 64; 581-588. IF: TBD (IF 2008: 6.20)
71. Siebenhaar, F., Degener, F., Zuberbier, T., Martus, P., and Maurer, M.: High-dose Desloratadine decreases wheal volume and improves cold provocation thresholds as compared with standard dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study. J. Allergy Clin. Immunol. 2009: 123; 672-679. IF: TBD (IF 2008: 9.77)
72. Altrichter, S., Boodstein, N., and Maurer, M.: Matrix metalloproteinase-9: A novel biomarker for monitoring disease activity in patients with chronic urticaria? Allergy 2009: 64; 652-656. IF: TBD (IF 2008: 6.20)
73. Metz, M., Gimenez-Arnau, A., Borzova, E., Grattan, C. E. H., Magerl, M., and Maurer, M.: Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J. Allergy Clin. Immunol. 2009: 123; 705-706. IF: TBD (IF 2008: 9.77)
74. Metz, M., Gimenez-Arnau, A., Borzova, E., Grattan, C. E. H., Magerl, M., and Maurer, M.: Comment on “Is the autologous plasma skin test in patients with chronic urticaria really useless? J. Allergy Clin. Immunol. 2009: 123; 1417
75. Potter, P. C., Kapp, A., Maurer, M., Guillet, G., Jian, A. M., Hauptmann, P., and Finlay, A. Y.: Comparison of the efficacy of levocetirizine 5 mg versus desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy 2009: 64; 596-604. IF: TBD (IF 2008: 6.20)
76. Mrabet-Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T., and Maurer, M.: Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 2009: 18; 437-444. IF: TBD (IF 2008: 3.26)
77. Metz, M.*, Magerl, M.*, Kühl, N. F., Valeva, A., Bhakdi, S., and Maurer, M.: Mast cells determine the magnitude of bacterial toxin-induced skin inflammation. Exp. Dermatol. 2009: 18; 160-166. IF: TBD (IF 2008: 3.26)
78. Młynek, A., Magerl, M., Hanna, M., Lhachimi, S., Baiardini, I., Canonica, G. W., Brzoza, Z., Kasperska-Zajac, A., Rogala, B., Zalewska-Janowska, A., Zuberbier, T., and Maurer, M.: The German version of the chronic urticaria quality-of-life questionnaire (CU-Q2oL): Factor analysis, validation and initial clinical findings. Allergy 2009: 64; 927-936. IF: TBD (IF 2008: 6.20)
79. Magerl, M., Schmolke, J., Metz, M., Zuberbier, T., Siebenhaar, F., and Maurer, M.: Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin. Exp. Dermatol. 2009: 34; e137-e140. IF: TBD (IF 2008: 1.78)
80. Giménez-Arnau, A., Izquierdo, I., and Maurer, M.: The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J. Eur. Acad. Dermatol. Venereol. 2009: 23; 1088-1091. IF: DNA
81. Zuberbier, T., Asero, R., Bindslev-Jensen, C., Canonica, G. W., Church, M. K., Giménez-Arnau, A. M., Grattan, C. E. H., Kapp, A., Maurer, M., Merk, H. F., Rogala, B., Saini, S., Sánchez-Borges, M., Schmid-Grendelmeier, P., Schünemann, H., Staubach, P., Vena, G. A., and Wedi, B.: EAACI/GA2LEN/EDF/WAO Guideline: Management of Urticaria. Allergy 2009: 64; 1427-1443. IF: TBD (IF 2008: 6.20)
82. Zuberbier, T., Asero, R., Bindslev-Jensen, C., Canonica, G. W., Church, M. K., Giménez-Arnau, A. M., Grattan, C. E. H., Kapp, A., Merk, H. F., Rogala, B., Saini, S., Sánchez-Borges, M., Schmid-Grendelmeier, P., Schünemann, H., Staubach, P., Vena, G. A., Wedi, B., and Maurer, M.:EAACI/GA2LEN/EDF/WAO Guideline: Definition, Classification and Diagnosis of Urticaria. Allergy 2009: 64; 1417-1426. IF: TBD (IF 2008: 6.20)
83. Weller, K. and Maurer, M.: Desloratadine inhibits human skin mast cell activation and histamine release. J. Invest. Dermatol. 2009: 129; 2723-2726. IF: TBD (IF 2008: 5.25)
84. Schulz, S., Metz, M., Siepmann, D., Luger, T. A., Maurer, M., and Ständer, S.: Antipruritic efficacy of a high-dosage antihistamine therapy: Results of a retrospectively analysed case series. Hautarzt 2009: 60; 564-568. IF: 0.36
85. Konstantinou, G. N., Asero, R., Maurer, M., Sabroe, R. A., Schmid-Grendelmeier, P., Grattan, C. E. H.: EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009: 64; 1256-1268. IF: TBD (IF 2008: 6.20)
86. Magerl, M., Borzova, E., Giménez-Arnau, A., Grattan, C. E. H., Lawlor, F., Mathelier-Fusade, P., Metz, M., Młynek, A., and Maurer, M.: The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009: 64; 1715-1721. IF: TBD (IF 2008: 6.20)
87. Magerl, M., Pisarevskaja, D., Scheufele, R., Zuberbier, T., and Maurer, M.: Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: A prospective trial. Allergy 2010: 65; 78-83. IF: TBD (IF 2008: 6.20)
88. Bachert, C. and Maurer, M.: Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria. Results of four postmarketing surveillance studies. Clin. Drug Inv. 2010: 30; 109-122. IF: TBD (IF 2008: 1.30)
89. Krause, K., Metz, M., Zuberbier, T., Maurer, M., and Magerl, M.: Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant. J. Dtsch. Dermatol. Ges. 2010: in press. IF: DNA
90. Młynek, A., Magerl, M., Siebenhaar, F., Weller, K., Vieira dos Santos, R., Zuberbier, T., Zalewska-Janowska, A., and Maurer, M.: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br. J. Dermatol. 2010: in press. IF: TBD (IF 2008: 3.49)
91. Cicardi, M., Aberer, W., Arcoleo, F., Bas, M., Björkander, J., Bouillet, L., Bull, C., Cillari, E., Farkas, H., Feighery, C., Floccard, B., Grabbe, J., Greve, J., Hoffmann, T. K., Kaatz, M., Kivity, S., Kreuz, W., Luger, T., Martin, L., Maurer, M., Merk, H., Obtulowicz, K., Pichler, C., Reshef, A., Sitkauskiene, B., Toubi, E., Werner, S., Knolle, J., Kravec, I., Rosenkranz, B., Dong, L., Zimmermann, J., and Bork, K.: Icatibant, a novel bradykinin B2 receptor antagonist, is effective in the treatment of acute attacks in patients with hereditary angioedema. N. Engl. J. Med. 2010: in press. IF: TBD (IF 2008: 50.02)
92. Hartmann, K.*, Siebenhaar, F.*, Belloni, B., Brockow, K., Eben, R., Hartmann, B., Ruëff, F., Schoepke, N., Staubach, P., Weber, A., and Maurer, M.: Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized double-blind, placebo-controlled trial. Br. J. Dermatol. 2010: in press. IF: TBD (IF 2008: 3.49)
93. Metz, M., Scholz, E., Ferrán, M., Izquierdo, I., Giménez-Arnau, A., and Maurer, M.: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann. Allergy Asthma Immunol. 2010: in press. IF: TBD (IF 2008: 2.35)
94. Vieira dos Santos, R., Magerl, M., Martus, P., Zuberbier, T., Church, M. K., Escribano, L., and Maurer, M.: Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br. J. Dermatol. 2010: in press. IF: TBD (IF 2008: 3.49)
95. Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Gerth van Wijk, R., La Grutta, S., Lombardi, C., Maurer, M., Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Bom, A. T., Bousquet, J., Zuberbier, T., and Braido, F.: Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA2LEN taskforce position paper. Allergy 2010: in press. IF: TBD (IF 2008: 6.20)
96. Hartmann, K., Biedermann, T., Brockow, K., Grabbe, J., Horny, H.-P., Lippert, U., Maurer, M., Raithel, M., Rietschel, E., Ruëff, F., Sotlar, K. für das Kompetenznetzwerk Mastozytose e. V.: Leitlinie Mastozytose. JDDG 2010: in press. IF: DNA
97. Dudeck, A., Grusser, M., Dudeck, J., and Maurer, M.: Immature mast cells exhibit strong adhesion to skin endothelial cells and subsequent transendothelial migration. Exp. Dermatol. 2010: in press. IF: TBD (IF 2008: 3.26)
98. Church, M. K., Maurer, M., Simons, F. E. R., Bindslev-Jensen, C., van Cauwenberge, P., Bousquet, J., T Holgate, S. T., and Zuberbier, T.: Should first-generation H1-antihistamines still be available as over-the-counter medications? A GA²LEN task force report. Allergy 2010: in press. IF: TBD (IF 2008: 6.20)
99. Zuberbier, T., Balke, M., Worm, M., Edenharter, G., and Maurer, M.: Epidemiology of urticaria – A prospective representative cross-sectional population survey. Clin. Exp. Dermatol. 2010: in press. IF: TBD (IF 2008: 1.78)
100. Kring Tannert, L., Stahl Skov, P., Bjerremann Jensen, L., Maurer, M., and Bindslev-Jensen, C.: Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction. Clin. Exp. Dermatol. 2010: under revision. IF: TBD (IF 2008: 1.78)

Reviews in Peer-reviewed Journals

1. Galli, S. J., Maurer, M., and Lantz, C. S.: Mast cells as sentinels in innate immunity. Curr. Opin. Immunol. 1998: 11; 53-59. IF: 11.03
2. Henz, B. M., Maurer, M., Lippert, U., Worm, M., and Babina, M.: Mast cells as initiators of immunity and host defense. Exp. Dermatol. 2001: 10; 1-10. IF: 2.23
3. Tokura, Y., Röcken, M., Clark, R. A. F., Maurer, M., Grabbe, S., Haliasos, E., Takigawa M., and Sinha, A. A.: What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Exp. Dermatol. 2001: 11; 128-140. IF: 2.23
4. Maurer, M., Hanau, A., Metz, M., Magerl, M., and Staubach, P.: Relevanz von Nahrungsmittelallergien und –intoleranzreaktionen als Ursachen von Urtikaria. Hautarzt 2003: 54; 138-143. IF: 0.52
5. Maurer, M., Theoharides, T., Granstein, R., Kovanen, P. T., Bischoff, S. C., Befus, D., Vliagoftis, H., Forsythe, P., Kambe, N., Miyachi, Y., Henz, B. M., Piliponsky, A. M., Levi-Schaffer, F., Kitamura, Y., Bienenstock, J., and Galli, S. J.: What is the physiological function of mast cells? Exp. Dermatol. 2003: 12; 886-910. IF: 2.04
6. Maurer, M., Metz, M., Magerl, M., Siebenhaar, F., and Staubach, P.: Autoreactive urticaria and autoimmune urticaria. Hautarzt 2004: 55; 350-356. IF: 0.46
7. Maurer, M., and Zuberbier, T.: Immer wieder Urtikaria. Leitlinien zur Diagnostik der chronischen Urtikaria. Der Deutsche Dermatologe 2004: 7; 471-474. IF: DNA
8. Maurer, M., and von Stebut, E.: Macrophage inflammatory protein-1. Int. J. Biochem. Cell. Biol. 2004: 36; 1882-1886. IF: 3.58
9. Biró, T., Ko, M. C., Bromm, B., Wei, E. T., Bigliardi, P., Siebenhaar, F., Hashizume, H., Misery, L., Baserga, N., Kamei, C., Schouenborg, J., Roostermann, D., Szabó, T., Maurer, M., Bigliardi-Qi, M., Meingassner, J. G., Hossen, M. A., Schmelz, M., and Steinhoff, M.: How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp. Dermatol. 2005: 14; 225-240. IF: 2.09
10. Maurer, M., and Metz, M.: The status quo and quo vadis of mast cells. Exp. Dermatol. 2005: 14; 923-929. IF: 2.09
11. Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M., Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B.: EAACI/GA²LEN guideline: Management of urticaria. Allergy 2006: 61; 321-331. IF: 5.33
12. Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M., Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B.: EAACI/GA²LEN guideline: Definition, classification, and diagnosis of urticaria. Allergy 2006: 61; 316-320. IF: 5.33
13. Maurer, M., Siebenhaar, F., Syska, W., and Magerl, M.: Ätiopathogenese der akuten und der chronischen Urtikaria. Allergo J. 2006: 15; 199-204. IF: DNA
14. Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E., and Bíró, T.: Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J. Invest. Dermatol. 2006: 126; 1705-1718. IF: 4.54
15. Bousquet, J., Anto, J. M., Bachert, C., Bousquet, P. J., Colombo, P., Crameri, R., Daeron, M., Fokkens, W., Leynaert, B., Lahoz, C., Maurer, M., Passalacqua, G., Valenta, R., van Hage, M., and van Ree, R.: Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 2006: 61; 671-680. IF 5.33
16. Schröder, J. M., Reich, K., Kabashima, K., Liu, F. T., Romani, N., Metz, M., Kerstan, A., Lee, P. H. A., Loser, K., Schön, M. P., Maurer, M., Stoitzner, P., Beissert, S., Tokura, Y., and Gallo, R. L.: Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 2006: 15; 913-929. IF: 2.45
17. Magerl, M. and Maurer, M.: Urtikaria - From bench to bedside. Hautarzt 2007: 58; 308-313. IF: 0.33
18. Zuberbier, T. and Maurer, M.: Urticaria: Current opinions about etiology, diagnosis and therapy. Acta Derm. Venereol. 2007: 87; 196-205. IF: 1.93
19. Metz, M. and Maurer, M.: Mast cells - key effector cells in immune responses. Trends Immunol. 2007: 28; 234-241. IF: 9.48
20. Siebenhaar, F., Weller, K., Młynek, A., Magerl, M., Altrichter, S., Vieira dos Santos, R., Maurer, M., and Zuberbier, T.: Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin. Exp. Dermatol. 2007: 32; 241-245. IF: 1.52
21. Maurer, M., and Staubach, P.: Praktische Tipps für die Betreuung von Patienten mit Urtikaria. Allergologie 2007: 6; 211-215. IF: 0.16
22. Schröder, N. W. J. and Maurer, M.: The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007: 62; 579-590. IF: 5.01
23. Weller, K. and Maurer, M.: Aktuelle wissenschaftliche Erkenntnisse zur Mastzelle: Bedeutung für die Praxis. Allergologie 2007: 6; 206-210. IF: 0.16
24. Mullol, J., Bousquet, J., Bachert, C., Canonica, W. G., Gimenez-Arnau, A., Kowalski, M. L., Marti-Guadano, E., Maurer, M., Picado, C., Scadding, G., and van Cauwenberge, P.: Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008: 63; 5–28. IF: 6.20
25. Taube, C. and Maurer, M.: Role of mast cells in the development of allergic asthma. Allergo J. 2008: 17; 297-300. IF: DNA
26. Magerl, M., Altrichter, S., Boodstein, N., Güzelbey, O., Keßler, B., Krause, K., Metz, M., Weller, K., Zuberbier, T., and Maurer, M.: Urticaria – classification and strategies for diagnosis and treatment. CME Dermatol. 2008: 3; 2-18. IF: DNA
27. Maurer, M. and Grabbe, J.: Urtikaria – gezielte Anamnese und ursachenorientierte Therapie. Dtsch. Arztebl. 2008: 105; 458-466. IF: DNA
28. Metz, M., Siebenhaar, F. and Maurer, M.: Mast cell functions in the innate skin immune system. Immunobiology 2008: 213; 251-260. IF: 3.46
29. Młynek, A., Maurer, M., and Zalewska, A.: Update on chronic urticaria: focusing on mechanisms. Curr. Opin. Allergy Clin. Immunol. 2008: 8; 433-437. IF: 3.50
30. Mullol, J., Maurer, M., and Bousquet, J.: Sleep and allergic rhinitis. J. Investig. Allergol. Clin. Immunol. 2008: 18; 415-419. IF: 1.25
31. Kirchhoff, D., Bischoff, S. C., Maurer, M., and Zollner, T. M.: Mast cells in health and disease: from basic science to clinical application. Expert Opin. Ther. Tar. 2008: 12; 1591-1594. IF: 4.04
32. Maurer, M., Dondji, B., and von Stebut, E.: What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med. Microbiol. Immunol. 2009: 198; 137-146. IF: TBD (IF 2008: 2.22)
33. Hakim-Rad, K., Metz, M., and Maurer, M.: Mast Cells – Makers and Breakers of allergic inflammation. Curr. Opin. J. Allergy Clin. Immunol. 2009: 9; 427-430. IF: TBD (IF 2008: 10.45)
34. Metz, M. and Maurer, M.: Innate immunity and allergy in the skin. Curr. Opin. Immunol. 2009: 21; 687-693. IF: TBD (IF 2008: 10.45)
35. Maurer, M.: Cold urticaria: a management model for difficult-to-treat chronic urticaria. Ann. Dermatol. Vener. 2009: 136; 15-18. IF: TBD (IF 2008: 0.48)
36. Krause, K., Metz, M., Magerl, M., and Maurer, M.: Prevalence and relevance of skin autoreactivity in chronic urticaria. Expert Rev. Dermatol. 2009: 4; 655-663. IF: DNA

Book Chapters

 

1. Maurer, M. Allergie - was ist das? In: Henning, T., and Maurer, M., editors. Allergien im Kindesalter. Neuwied: Luchterhand Verlag, 1998.
2. Maurer, M. Insektengiftallergie. In: Henning, T., and Maurer, M., editors. Allergien im Kindesalter. Neuwied: Luchterhand Verlag, 1998.
3. Maurer, M. Allergie vom Soforttyp (Typ I) – Mastzellen und Frühphasenreaktion. In: Saloga, J., Klimek, L., Buhl, R., Mann, W., and Knop, J., editors. Allergologie-Handbuch Grundlagen und klinische Praxis. Stuttgart: Schattauer Verlag, 2006, 70-81.
4. Maurer, M., and Staubach, P. Einführung. In: Maurer, M., and Staubach, P., editors. Juckreiz, Quaddeln, Nesselsucht. Hamburg: Akademos Verlag, 2006, 6-19.
5. Maurer, M., Worm, M., and Zuberbier, T. Antihistamines in atopic dermatitis. In: Reitamo, S., Luger, T. and Steinhoff, M., editors. Textbook of atopic dermatitis. London: Informa UK Ltd; 2007.
6. Magerl, M., and Maurer, M. Hereditäres Angioödem, In: Schöfer, H., and Baur-Beger, S., editors. Derma-Net-Online: Aktuelle Dermatologie für Dermatologen und dermatologisch Interessierte (www.derma-net-online.de); 2007.
7. Siebenhaar, F., and Maurer, M. Mastozytose. In: Schöfer, H., and Baur-Beger, S., editors. Derma-Net-Online: Aktuelle Dermatologie für Dermatologen und dermatologisch Interessierte (www.derma-net-online.de); 2007.
8. Maurer, M. Mastocytosis. In: Burgdorf, W. H. C., Plewig, G., Wolff, H. H., and Landthaler, M., editors. Braun-Falco’s Dermatology. 3rd ed., Heidelberg: Springer, 2008.
9. Maurer, M. in: Sterry, W., and Paus, R. editors. Thieme-Verlag Stuttgart: Checkliste Dermatologie – 27.1 Tumoren der Mastzellen; 6. Auflage; 2009: in press
10. Maurer, M. in: Sterry, W., and Paus, R. editors. Thieme-Verlag Stuttgart: Checkliste Dermatologie – 10. Allergische Erkrankungen: Immunologische Grundlagen, Urtikaria, Angioödem – 6. Auflage; 2009: in press
11. Siebenhaar, F., Metz, M., and Maurer, M. Mast Cell-driven Skin Responses beyond Type I Allergic Reactions in: Jaypee Bro. Publisher, New Delhi, India: Immunology of Ocular Allergy; 2009

Books

1. Henning, T., and Maurer, M., editors. Allergien im Kindesalter. Neuwied: Luchterhand Verlag, 1998.
2. Maurer, M., and Staubach, P., editors. Juckreiz, Quaddeln, Nesselsucht. Hamburg: Akademos Verlag, 2006.
3. Maurer, M., and Staubach, P., editors. Urtikaria: 100 Fragen – 100 Antworten. Hamburg: Akademos Verlag, 2006.
4. Zuberbier, T., Grattan, C., and Maurer, M., editors. Urticaria – A Practical Manual. Heidelberg: Springer Verlag, 2009.